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INTRODUCTION 51
assigned confidence scores assuming equal allele fractions for the diploid genome (varScoreEAF) . A Bayesian probability model was used to evaluate potential locus calls. The 154 model accounted for read depth, base call quality scores, mapping/alignment probabilities, and 155 empirical priors on gap sizes and discordance rates 34 . Based on the relative allele likelihoods a 156 quality score was assigned for the chosen call:
to minimize the number of false positive calls: (i) variants with VQLOW allele tags were removed; (ii) variants in microsatellite regions were removed; (iii) variants within simple tandem repeat regions were removed; (iv) three or more SNPs clustered within a distance of were considered as true positive (TP) calls, while those that were discordant between 187 replicates were considered false positives (FP). Accordingly, concordant variant calls that fell 188 below a given depth and quality threshold were classified as false negative (FN) and discordant 189 calls that fell below a given depth and quality threshold were classified as true negative (TN).
190
Optimal depth and quality score thresholds were determined by selecting the thresholds that 191 yielded the greatest Matthews correlation coefficient (MCC) values across each variant type 37 : 192 !"" = !"×!" − !"×!"
(!" + !")(!" + !")(!" + !")(!" + !")
The thresholds chosen for association testing corresponded with the greatest MCC values for 193 each variant type (Table S2 ).
194
Assessing deleteriousness
195
After filtering for rare variants called with high confidence, as described above, variants were 196 further characterized according to their predicted effects. Only variants that were predicted to 197 have a deleterious effect were included in the association testing. Deleteriousness was 198 primarily assessed using the Combined Annotation Dependent Depletion (CADD) tool 41 , which 199 is trained on output from numerous annotation programs to predict deleteriousness based on 200 conservation relative to our ancestral genome. Variants were retained if they produced a CADD 201 score greater than the gene-specific mutation significance cutoff (MSC; 95% confidence 202 interval) suggested by Itan et al. 42 are more likely to be reported falsely as disease-associated 71 .
231
Sequence kernel association test (SKAT) statistics were computed using the methods described 232 in Schaid et al. 72 , which account for pedigree information in calculating trait associations.
233
Custom variant weights were applied for each variant according to their CADD Phred scores:
where Cv is the CADD Phred score for variant v, g is the gene or window, MSCG is the mutation 235 significance threshold for g, and G is the set of all variants within the genome. In this way,
236
variants that are more likely to be deleteriousness were weighted more heavily than variants
237
where the functional consequences are less likely to be damaging. For the dichotomous trait 
248
Quantitative trait meta-analysis
249
For complex diseases with multivariate phenotypes, combining multiple related phenotypic 250 traits into one analysis can increase power in finding disease associations 75, 76 . We combined 251 the six aforementioned quantitative trait associations into one meta-statistic using a Fisher 252 combination function modified to account for correlated traits 77 . Inter-trait correlations were 253 determined using the Pearson correlation coefficient ( Fig. S4) . P-values were adjusted using
254
Bonferroni correction according to the number of variant groupings that were tested that 255 contained at least one variant, as well as by the genomic inflation factor, λ. Correlation between 256 meta-analysis association results and dichotomous trait association results were calculated 257 using Spearman's coefficient.
258
The characteristic disturbance of gonadotropin secretion associated with PCOS is increased LH 259 relative to FSH release 78 . For genes with significant meta-analysis associations, LH:FSH ratios 260 were compared between variant carriers and non-carriers using a Wilcoxon's rank sum test,
261
adjusted for multiple testing (Bonferroni). Differences in LH:FSH ratios between variant 262 carriers and non-carriers would indicate that the gene variants alter gonadotropin signaling.
263
In silico binding effect prediction
264
To assess the potential functional effects of noncoding variants identified in the quantitative 265 trait meta-analysis, we predicted the corresponding impacts to transcription factor (TF) and all subsequences overlapping the SNV position on each strand within a ±20bp window. Binding given sequence across a motif PWM. Binding p-values were defined as the probability that a 272 sequence sampled from a genomic background distribution had an affinity score greater than 273 or equal the largest affinity score produced from one of the tested subsequences. Genomic 274 background sequences were generated using a first order Markov model 79 
289
The identified SNVs were likewise analyzed for potential alteration to RNA-binding protein 290 (RBP) sites following the same procedure but for a few modifications. RBPs and their binding 291 affinity scores were determined using the ATtTRACT database 84 . Only sequences on the coding 292 strand were evaluated as to reflect the mRNA sequences. Additionally, significant changes in the alternate allele was predicted to induce RBP binding were also included.
For additional details regarding methodological considerations and rationale, please refer to 298 the Appendix.
299
300
RESULTS 301
Characteristics of study population
302
The characteristics of the study population, including counts and trait distributions by familial 303 relation and the numbers of subjects included in each association test, are summarized in 304 
370
The expression of V2 was increased in PCOS theca cells 87 . Forced expression of the V2 371 transcript produced a PCOS phenotype in normal theca cells, whereas knockdown of V2 in 372 PCOS theca cells reduced thecal androgen biosynthesis 87 . Urine exosomal V2 mRNA was also 373 increased in PCOS women 87 . Taken together, these findings provide strong support for the 374 hypothesis that DENND1A plays a role in PCOS pathogenesis. The increased LH:FSH ratios that 375 we observed in the DENND1A rare variant carriers ( Fig. 1) suggest that DENND1A plays a role 376 in the regulation of gonadotropin secretion 89 .
377
The DENND1A risk variants identified by GWAS are located in introns and the functional 378 consequences of these variants are unknown 56 . There have been no large-scale sequencing 379 studies reported to map causal variants in DENND1A 85 . Targeted 87, 90 and whole exome 380 sequencing 91 in small cohorts of PCOS women have failed to identify any coding variants in 381 DENND1A that were associated with PCOS or with V2 isoform expression. Genomic sequencing 382 of the intronic region where V1 and V2 are alternatively spliced also failed to identify any 383 variants that consistently favored V2 expression in a study of 20 normal and 19 PCOS women 56 . study were found in 50% of families, but each individual variant was typically found in only 392 one or two families. Our findings, therefore, support a model of PCOS in which causal variants 393 are individually uncommon but collectively tend to occur in key genes. Our recent findings 92 of 394 multiple rare exonic rare variants in the AMH gene that reduce its biologic activity in ~3% of 395 women with PCOS is consistent with this model.
396
Our results also align with the emerging evidence that rare coding variants with large effect 397 sizes do not play a major role in complex disease 93 . Rather, it appears that complex traits are 398 primarily driven by noncoding variation 94, 95 , both common and rare 96, 97 . Of the 32 rare 399 variants predicted as deleterious that we identified in DENND1A, 30 were noncoding. Rare 400 variant association studies typically require very large sample sizes 98 
411
Several established PCOS candidate genes besides DENND1A appeared among the top gene 412 associations, but failed to reach genome-wide significance. These genes included previously 413 reported PCOS GWAS susceptibility loci, C9orf3, HMGA2, ZBTB16, TOX3, and THADA (Fig. 3) .
414
Two additional genes with strong, but not genome-wide-significant, associations with PCOS 415 quantitative traits are highly plausible PCOS candidate genes. BMP6 had the third strongest Table 2 ). PRDM2 is an estrogen receptor co-activator 105 that is highly expressed in the ovary 423 and pituitary gland 83 . Ligand bound estrogen receptor alpha (ERα) binds with PRDM2 to open 424 chromatin at ERα target genes 105, 106 . PRDM2 also binds with the retinoblastoma protein 107 , 425 which has been shown to play an important role in follicular development in granulosa cells 108, 
427
The central statistical challenge in studying rare variants is achieving adequate power to detect 428 significant associations while controlling for Type I error. The family-based structure of our 429 cohort provided an enrichment of individual rare variants and enabled modeling of familial 430 segregation 110 . To mitigate variant calling errors, we utilized replicate samples from one family 431 to determine optimal read depth and quality thresholds. To remove irrelevant variants from 432 consideration, we applied a LINSIGHT score threshold and gene-specific CADD score 433 thresholds 72 to filter for deleteriousness. We further prioritized variants by weighting them by 434 their relative CADD scores. To group rare variants effectively, we applied several windows-435 based binning methods, in addition to the gene-based approach, to ensure that different kinds 436 of functionally-correlated genomic regions were tested, both of fixed length and of variable 437 length. To limit our search to genes that were more likely to have specific roles in PCOS 438 etiology, we only considered genes with rare deleterious variants in at least 10% of cases, as 439 causal rare variants are more likely to accumulate in core disease genes 94 . We greatly increased 440 our power to detect relevant disease genes and account for pleiotropic effects by consolidating 441 quantitative trait association results into a meta-analysis 75, 76 . In order to reduce Type I error, 442 in addition to the variant calling quality control measures, we modeled the quantitative traits 443 against skewed distributions and further normalized trait residuals using an INT.
444
Given the size of our cohort, it was necessary to apply relatively strict filters based on predicted 445 variant effects and cumulative allele frequencies in order to detect rare variant associations.
446
Very large sample sizes are otherwise required for WGS studies of rare variants 98 . By only Table 1 
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